There is the potential for it to be worth $125 a share or more, as has been pointed out before Gillead paid $11 billion for a hepatitis focused biotech in 2011. If we cure hcv and nsc lung cancer starts looking good then $100 will look cheap, if the technology platform we have is the real deal then I think even the wildest predictions might be conservative given how many things it could be applied to.
- Forums
- ASX - By Stock
- BLT
- are we worth $25
are we worth $25, page-3
-
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
UNT
UNITH LTD
Idan Schmorak, CEO
Idan Schmorak
CEO
Previous Video
Next Video
SPONSORED BY The Market Online